ClinVar Miner

Submissions for variant NM_001142864.4(PIEZO1):c.5040C>A (p.Tyr1680Ter)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV004018307 SCV004847474 likely pathogenic Diffuse lymphatic malformation 2024-03-29 criteria provided, single submitter clinical testing The p.Tyr1680X variant in PIEZO1 has not been previously reported in individuals with generalized lymphatic dysplasia but has been identified in 0.0005% (5/1078764) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org, v.4.0.0), consistent with a recessive carrier frequency. This nonsense variant leads to a premature termination codon at position 1680, which is predicted to lead to a truncated or absent protein. Biallelic loss of function of the PIEZO1 gene is an established disease mechanism in autosomal recessive generalized lymphatic dysplasia. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalis. ACMG/AMP Criteria applied: PVS1, PM2_Supporting.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.